SMCI Supports the Disability Integration Act

SMCI is proud to join 400 other organizations in supporting the Disability Integration Act The pending Disability Integration Act (Senate Resolution 2427) marks a key shift in the approach to disability services and definitions that could have substantial impact on the lives of patients with myalgic encephalomyelitis (ME), commonly known as chronic fatigue syndrome (CFS). […]

Read More

CDC Convenes In-Person Meeting of Its Technical Development Workgroup (TDW)

The long-awaited, in-person meeting for members of the Centers for Disease Control and Prevention (CDC) Technical Development Workgroup (TDW) took place on September 26, 2016, in Atlanta, GA. The advocacy community has long been frustrated that information on the CDC website, which is an important “go to” source of information for patients, doctors and other […]

Read More

New Research Project Launches through SMCI’s Targeted Initiative Research Program

SMCI recently launched a new partnership as a component of our targeted initiative program, within our Pathways and Biomarkers Discovery Track. The project consists of original research in the areas of bioenergetics, metabolomics, and lipidomics using high-throughput technology. Importantly, this new SMCI research project relies on blood from well-qualified patients from The Levine Clinic; it […]

Read More

October Research 1st – Dr. Nahle’s Letter

Dear Friends, Earlier this year, we announced the formation of our Research Advisory Council (RAC), consisting of leading ME/CFS experts and thought leaders across many disciplines. This distinguished assembly met in person last weekend for a full day of workshops, discussions, and lectures as part of our annual gathering, which took place this year in […]

Read More